renal anemia

Known as: anemia renal, renal anaemia 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1974-2017
0102019742017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Studies over the last two decades have established tubulointerstitial hypoxia as a final common pathway leading to end-stage… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
The Japanese Society for Dialysis Therapy (JSDT) guideline committee, chaired by Dr Y. Tsubakihara, presents the Japanese… (More)
Is this relevant?
2010
2010
BACKGROUND Several studies with erythropoiesis-stimulating agents claim that maintenance therapy of renal anaemia may be possible… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2010
2010
1. Recombinant human erythropoietin (rHuEPO) has been used for the management of renal anaemia. Recent studies suggest… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2007
2007
BACKGROUND Iron supplementation is a mainstay for management of renal anaemia in patients receiving haemodialysis (HD). Although… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND AND AIMS The hepatic peptide hormone hepcidin, which has recently been isolated from human plasma and urine, is… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Circulating bone marrow-derived endothelial progenitor cells (EPCs) promote vascular reparative processes and neoangiogenesis… (More)
Is this relevant?
2003
2003
BACKGROUND Darbepoetin alfa is an erythropoietic agent with a 3-fold longer elimination half-life than recombinant human… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
1995
1995
BACKGROUND rHuEpo and iron therapy corrects renal anaemia. However, dosage, route of administration, and monitoring of iron and… (More)
Is this relevant?
1990
1990
The long-term cardiorespiratory effects of recombinant human erythropoietin treatment were investigated in ten haemodialysis… (More)
Is this relevant?